UK markets close in 7 hours 32 minutes

UnitedHealth Group Incorporated (0R0O.IL)

IOB - IOB Delayed price. Currency in USD
Add to watchlist
493.30+1.57 (+0.32%)
As of 07:53AM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 453.57B
Enterprise value 494.50B
Trailing P/E 30.22
Forward P/E 17.79
PEG ratio (5-yr expected) 1.40
Price/sales (ttm)1.22
Price/book (mrq)4.93
Enterprise value/revenue 1.30
Enterprise value/EBITDA 16.98

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 30.25%
S&P500 52-week change 321.33%
52-week high 3554.48
52-week low 3436.45
50-day moving average 3485.10
200-day moving average 3509.68

Share statistics

Avg vol (3-month) 350.64k
Avg vol (10-day) 3116.72k
Shares outstanding 5926.31M
Implied shares outstanding 6926.31M
Float 8932.46M
% held by insiders 10.27%
% held by institutions 188.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 47.06
Forward annual dividend yield 41.34%
Trailing annual dividend rate 37.06
Trailing annual dividend yield 31.44%
5-year average dividend yield 41.36
Payout ratio 430.57%
Dividend date 3N/A
Ex-dividend date 408 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 6.02%
Operating margin (ttm)8.77%

Management effectiveness

Return on assets (ttm)7.51%
Return on equity (ttm)25.30%

Income statement

Revenue (ttm)359.98B
Revenue per share (ttm)387.60
Quarterly revenue growth (yoy)14.20%
Gross profit (ttm)79.62B
EBITDA 34.54B
Net income avi to common (ttm)21.69B
Diluted EPS (ttm)22.33
Quarterly earnings growth (yoy)11.00%

Balance sheet

Total cash (mrq)44.1B
Total cash per share (mrq)47.11
Total debt (mrq)63.37B
Total debt/equity (mrq)67.43%
Current ratio (mrq)0.81
Book value per share (mrq)95.69

Cash flow statement

Operating cash flow (ttm)29.73B
Levered free cash flow (ttm)23.03B